Immune System News and Research

RSS

Hybrid nanoparticles image and treat tumors

By combining a magnetic nanoparticle, a fluorescent quantum dot, and an anticancer drug within a lipid-based nanoparticle, a multi-institutional research team headed by members of the National Cancer Institute's (NCI) Alliance for Nanotechnology in Cancer has created a single agent that can image and treat tumors. In addition, this new nanoparticle is able to avoid detection by the immune system, enabling the particle to remain in the body for extended periods of time.

28 Sep 2008

Researchers investigate impact of stress on police officers' physical and mental health

Policing is dangerous work, and the danger lurks not on the streets alone. The pressures of law enforcement put officers at risk for high blood pressure, insomnia, increased levels of destructive stress hormones, heart problems, post-traumatic stress disorder (PTSD) and suicide, University at Buffalo researchers have found through a decade of studies of police officers.

25 Sep 2008

Study of 'Big Eaters' could lead to better asthma treatments

A new study into the role of a particular immune cell in the lungs could lead to better treatments for the 5 million people in the UK affected by asthma.

23 Sep 2008

New technology to analyse human cells

A new technology which enables scientists to identify proteins by making a map of the energy flow inside the protein is revealed in Proceedings of the National Academy of Sciences (PNAS) journal.

23 Sep 2008

Coles contaminated chicken recalled in four states

The discovery that packs of pre-sliced chicken sold by the supermarket chain Coles were contaminated with listeria, has prompted a recall of the product from stores in New South Wales, South Australia, Victoria and Queensland and Coles Online.

23 Sep 2008

Exposure to bacteria might prevent type I diabetes

Researchers from Yale University and the University of Chicago have found a startling illustration of the potential for microbes to prevent disease - they found that mice exposed to common stomach bacteria were protected against the development of type I diabetes.

22 Sep 2008

Research provides new insights into how cells accessorize their proteins

St. Jude Children's Research Hospital investigators have gained new insight into how the cell's vast array of proteins would instantly be reduced to a confusion of lethally malfunctioning molecules without a system for proteins to "accessorize" in order to regulate their function.

21 Sep 2008

Flies reveal immune cell response to tumour and tissue damage

Research with fruit flies has revealed more in common between simple cuts and scratches and the growth of tumours than might have been expected.

17 Sep 2008

Combo of flu shot and COLD-FX cuts cold and flu by a third

A new study has shown the benefit of annual flu vaccinations for seniors along with Canada's top cold and flu-fighting product COLD-FX.

17 Sep 2008

Breast cancer vaccine could protect against aggressive HER2-positive breast tumours

Women with a certain type of breast cancer have been given hope in the form of a vaccine which promises to eliminate the cancer tumours.

16 Sep 2008

Study identifies immune response that enables TB bacteria to multiply, provides new target for TB drugs

Researchers have identified an immune system response to tuberculosis that enables TB bacteria to spread through the lungs, providing a new target for TB drug development, according to a study published Sunday in Nature Immunology, AFP/Washington Times reports.

16 Sep 2008

FDA grants approval to Talecris Biotherapeutics for Gamunex for neurological disorder CIDP

Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.

15 Sep 2008

An 'HIV-test' equivalent for early detection of lung cancer

A team of researchers led by Fred Hutchinson Cancer Research Center reports online today in the Journal of Clinical Oncology the validation of a potential "HIV-test" equivalent for the early detection of lung cancer. The test, which relies on immune-system signals, much like an HIV test, can detect the presence of lung cancer a year prior to diagnosis, long before symptoms appear.

15 Sep 2008

Vaccine against HER2-positive breast cancer offers complete protection in lab

Researchers at Wayne State University have tested a breast cancer vaccine they say completely eliminated HER2-positive tumors in mice - even cancers resistant to current anti-HER2 therapy - without any toxicity.

15 Sep 2008

Pathways to clinical goals speeds cancer therapy approval

Although cancer remains a leading cause of death in America, it can take up to 12 years to bring a new anti-cancer agent before the FDA and the success rate for approval is only five to 10 percent. That means many research hours and dollars are wasted chasing avenues that will not bring fruit.

15 Sep 2008

Senate approves bill to expand protections under Americans with disabilities act

The Senate on Thursday by voice vote approved a bill (S 3406) that would expand protections under the Americans with Disabilities Act, CongressDaily reports.

15 Sep 2008

DNA vaccine developed at the Karmanos Cancer Institute fights HER2-positive cancers

Researchers at the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine have developed a HER2 DNA vaccine that has shown to be effective on drug resistant tumors in mice. The study was reported in the September 15 issue of Cancer Research, a journal of the American Association for Cancer Research.

15 Sep 2008

Inovio Biomedical achieves 75% complete response rate in preclinical testing of DNA-based cancer vaccine using its electroporation DNA delivery system

Inovio Biomedical Corporation announced today that it achieved positive results from its proprietary research and development program for DNA-based cancer vaccines delivered using the company's electroporation-based DNA delivery technology.

15 Sep 2008

FDA approves Gamunex for chronic inflammatory demyelinating polyneuropathy

The U.S. Food and Drug Administration has announced that it has approved an immune globulin product called Gamunex for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), a rare autoimmune disorder characterized by progressive weakness and impaired sensory function in the legs and arms.

14 Sep 2008

Phase I trial for new tuberculosis vaccine

This week, a new vaccine "VPM1002" has entered the clinical phase I trial in Neuss, Germany, where it is being tested for safety on voluntary subjects. VPM1002 is based on a vaccine that has been in use since 1921, and has been genetically engineered to prevent infection with tuberculosis bacteria much more effectively than its predecessor.

11 Sep 2008

Immune System News and Research

Hybrid nanoparticles image and treat tumors

Researchers investigate impact of stress on police officers' physical and mental health

Study of 'Big Eaters' could lead to better asthma treatments

New technology to analyse human cells

Coles contaminated chicken recalled in four states

Exposure to bacteria might prevent type I diabetes

Research provides new insights into how cells accessorize their proteins

Flies reveal immune cell response to tumour and tissue damage

Combo of flu shot and COLD-FX cuts cold and flu by a third

Breast cancer vaccine could protect against aggressive HER2-positive breast tumours

Study identifies immune response that enables TB bacteria to multiply, provides new target for TB drugs

FDA grants approval to Talecris Biotherapeutics for Gamunex for neurological disorder CIDP

An 'HIV-test' equivalent for early detection of lung cancer

Vaccine against HER2-positive breast cancer offers complete protection in lab

Pathways to clinical goals speeds cancer therapy approval

Senate approves bill to expand protections under Americans with disabilities act

DNA vaccine developed at the Karmanos Cancer Institute fights HER2-positive cancers

Inovio Biomedical achieves 75% complete response rate in preclinical testing of DNA-based cancer vaccine using its electroporation DNA delivery system

FDA approves Gamunex for chronic inflammatory demyelinating polyneuropathy

Phase I trial for new tuberculosis vaccine

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News